Literature DB >> 6771071

Kinetic measurement of the interaction of rheumatoid factor with IgG-coated latex particles and the influence of the first component of human complement.

R Hällgren.   

Abstract

Interaction between isolated rheumatoid factor (RF) of the IgM class or sera from patients with rheumatoid arthritis (RA) and IgG-coated latex particles has been studied kinetically by means of standard aggregometer equipment. The agglutination of particles mediated by isolated RF or RA-sera is inhibited by fresh normal human serum (NHS). The RF-inhibiting principle is heat-labile and recovered in the high molecular weight fractions of NHS separated on a G-200 column. Partially purified first component of complement, C1, also inhibits RF-mediated particle agglutination and disintegrates preformed RF-IgG-latex particle agglutinates. Addition of C1 to heated (56 degrees C, 30 min) NHS restores its RF-inhibiting activity. The most probable basis of this serum activity is competition between C1 with higher affinity for IgG bound to particles and RF. After about 5 min of incubation of NHS with IgG-latex particles the RF-inhibiting activity is gradually lost and interpreted to mean that C1 during the activation of the complement system is discharged from IgG bound to particles. The RF-inhibiting activity of NHS gradually decreases by incubation of serum with increasing doses of activators of the classical complement pathway probably due to the inability of activated C1 to hinder RF-interaction with IgG-particles. The presence in certain RA-sera of C1 in mainly activated form explains why such sera, even if they are fresh are able to agglutinate IgG-particles.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771071      PMCID: PMC1537935     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Isolation of a thermolabile serum protein which precipitates gamma-globulin aggregates and participates in immune hemolysis.

Authors:  H J MULLER-EBERHARD; H G KUNKEL
Journal:  Proc Soc Exp Biol Med       Date:  1961-02

2.  Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.

Authors:  R H Zubler; U Nydegger; L H Perrin; K Fehr; J McCormick; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

Review 3.  Structure and activation of the early components of complement.

Authors:  R R Porter
Journal:  Fed Proc       Date:  1977-08

Review 4.  Complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Biochem       Date:  1969       Impact factor: 23.643

5.  Polymer enhancement of automated immunological nephelometric analysis, as illustrated by determination of urinary albumin.

Authors:  J Lizana; K Hellsing
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

6.  A comparison of methods for the molecular quantitation of the fourth component of human complement.

Authors:  N R Cooper; H J Müller-Eberhard
Journal:  Immunochemistry       Date:  1968-03

7.  Interaction of the rheumatoid factor with antigen-antibody complexes and aggregated gamma globulin.

Authors:  G M EDELMAN; H G KUNKEL; E C FRANKLIN
Journal:  J Exp Med       Date:  1958-07-01       Impact factor: 14.307

8.  Detection of circulating IgG aggregates and immune complexes using 125I protein A from Staphylococcus aureus.

Authors:  R Hällgren; L Wide
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

9.  Demonstration and quantitation of activation of the first component of complement in human serum.

Authors:  R J Ziccardi; N R Cooper
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

10.  Chromatographic resolution of the first component of human complement into three activities.

Authors:  I H LEPOW; G B NAFF; E W TODD; J PENSKY; C F HINZ
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.